Adial Pharmaceuticals, Inc. (NASDAQ:ADIL) Stock Now Rated “Hold” by Sell-Side Analysts
Adial Pharmaceuticals, Inc. (NASDAQ:ADIL – Get Free Report) has been given an average rating of “Hold” by the five ratings firms that are covering the stock, Marketbeat reports. One investment analyst has rated the stock with a sell recommendation, one has given a hold recommendation and three have assigned a buy recommendation to the company. […]
28 Sep 04:44 · The Cerbat Gem